SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 98
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermat... "PR Newswire (US)" - 4/20/2017 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/18/2017 4:38:12 PM
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes "PR Newswire (US)" - 4/18/2017 7:02:00 AM
Amended Statement of Beneficial Ownership (3/a) "Edgar (US Regulatory)" - 4/14/2017 5:38:06 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/12/2017 5:27:35 PM
RXi Pharmaceuticals to Present at the American Association for Cancer Research Annual Meeting "PR Newswire (US)" - 3/31/2017 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/30/2017 7:23:04 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/30/2017 7:04:13 AM
RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights "PR Newswire (US)" - 3/30/2017 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/29/2017 1:31:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/28/2017 11:52:36 AM
RXi Pharmaceuticals Granted Patent in Japan for Lead Clinical Candidate RXI-109 "PR Newswire (US)" - 3/28/2017 7:02:00 AM
RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum "PR Newswire (US)" - 3/22/2017 7:02:00 AM
RXi Pharmaceuticals to Present at the 2nd Annual Oligonucleotide and Peptide Therapeutics Conference "PR Newswire (US)" - 3/21/2017 7:02:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/20/2017 9:17:46 AM
RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2016 Financial Results on Thursday, March 30, 2017 "PR Newswire (US)" - 3/16/2017 7:02:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/21/2017 7:12:35 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/14/2017 10:29:46 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/14/2017 10:23:18 AM
RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board "PR Newswire (US)" - 2/14/2017 7:02:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/13/2017 11:33:03 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/8/2017 11:44:36 AM
RXi Pharmaceuticals to Present at Leading Investor and Healthcare Conferences "PR Newswire (US)" - 2/8/2017 7:02:00 AM
RXi Pharmaceuticals Appoints Leading Oncology Expert, Dr. Rolf Kiessling, to Scientific Advisory Board "PR Newswire (US)" - 2/7/2017 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/3/2017 5:27:19 PM
headshrink3   Saturday, 07/13/13 04:49:13 PM
Re: None
Post # of 4435 
They will have to be a reverse split otherwise nothing's going to happen and continued MM.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist